.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J07B_ViralVaccines.J07BC01_HepatitisBPurifiedAntige.HepatitisBPurifiedAntige .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J07B_ViralVaccines.J07BC01_HepatitisBPurifiedAntige.HepatitisBPurifiedAntige| name: | HepatitisBPurifiedAntigen | |
| ATC code: | J07BC01 | route: | intramuscular |
| compartments: | 1 | |
| dosage: | 20 | mg |
| volume of distribution: | 1 | L |
| clearance: | 0 | |
| other parameters in model implementation | ||
Purified hepatitis B antigen (also called hepatitis B vaccine) is an inactivated vaccine comprised of purified hepatitis B surface antigen (HBsAg). It is used to prevent infection by hepatitis B virus (HBV) and is routinely recommended for infants, children, and at-risk adults worldwide. It is approved and widely used in immunization programs globally.
No pharmacokinetic parameters for purified hepatitis B antigen vaccine in healthy adults or other populations are reported in published literature. As a protein antigen administered via intramuscular injection, it is not absorbed or distributed in the manner typical of small molecule drugs.